Page 58 - Roche Revista Argentina de Transfusión 1-2019

21. Musso D, Stramer SL; AABB Transfusion-Transmitted Diseases 24. Rasonglès P, Angelini-Tibert MF, Simon P, et al. Transfusion of
Committee, Busch MP; International Society of Blood Transfu- platelet components prepared with photochemical pathogen
sion Working Party on Transfusion-Transmitted Infectious Dis- inactivation treatment during a Chikungunya virus epidemic in
eases. Zika virus: a new challenge for blood transfusion. Lan- Ile de La Réunion. Transfusion 2009, 49:1083-91.
cet 2016, 387(10032):1993-4 25. Paturel C, et al. Prospective detection of Chikungunya virus in
22. WHO. Maintaining a safe and adequate blood supply during blood donors, Caribbean 2014. Blood 2014; 123, 3679-81.
Zika virus outbreaks. Interim guidance. WHO/ZIKV/HS/16.1, Feb- 26. Centers for Disease Control and Prevention (CDC).
ruary 2016. Transfusionrelated transmission of yellow fever vaccine virus—
23. FDA. Revised recommendations for reducing the risk of Zika California, 2009. MMWR Morb Mortal Wkly Rep 2010,59(2):34-
virus transmission by blood and blood components: guidance 7.
for industry. July 2018. Available at: https://www.fda.gov/
BiologicsBloodVaccines/GuidanceComplianceRegulatoryInfor-
mation/Guidances/default.htm.

Pág. 52 AAHITC - Lavalleja 1214 (C1414DTZ) Vol. XLV / N° 1 / 2019 Coordinadora: Dra. León de González, Graciela
Cdad. Aut. de Bs. As. - Argentina Págs. 49 / 52 Profesor invitado: Levi, José Eduardo
Tel/Fax: (54-11)4771-2501 - L.Rot.
E-mail: aahitc@aahitc.org.ar